SAN FRANCISCO, Could 25, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a number one medical genetics firm, in the present day introduced that Chief Monetary Officer (CFO) Yafei (Roxi) Wen is resigning to pursue different alternatives, efficient June 30, 2023. The Firm has initiated a seek for a brand new CFO. Ms. Wen will proceed in her position via the tip of the second quarter. Christine Gorjanc, the Firm’s longtime Chair of the Audit Committee of the Board of Administrators, will help throughout the transition and can assume the position of interim CFO, efficient July 1, 2023. Ms. Wen will work carefully with Ms. Gorjanc and the manager workforce to make sure a easy transition. Ms. Wen’s resignation isn’t the results of any disagreement with the Firm on any matter associated to the Firm’s operations, insurance policies or procedures.
“We’re immensely grateful for Roxi’s vital contributions to the Firm over the previous two years, and recognize her help throughout the transition. We want her solely one of the best in her future endeavors,” mentioned Ken Knight, president and chief government officer of Invitae. “We’re additionally lucky that Christine is stepping in at the moment. Christine’s prior CFO expertise with publicly-traded firms, her deep and related experience in finance and accounting, alongside together with her long-time tenure because the Chair of our Audit Committee with the Invitae Board of Administrators, make her an excellent useful resource for Invitae whereas we conduct the seek for our subsequent CFO.”
Ms. Gorjanc has been on the Firm’s Board of Administrators and Chair of the Audit Committee since November 2015. She served because the CFO of Arlo Applied sciences, Inc. from August 2018 to June 2020. She beforehand served as CFO of NETGEAR, Inc. from January 2008 to August 2018 and in addition held the roles of chief accounting officer and vice chairman of Finance at NETGEAR, Inc.
Ms. Wen mentioned, “It has been a privilege working alongside such distinctive groups, and I really feel assured within the interim management of Christine, as the corporate appears to execute on its imaginative and prescient.”
Invitae (NYSE: NVTA) is a number one medical genetics firm trusted by hundreds of thousands of sufferers and their suppliers to ship well timed genetic info utilizing digital expertise. We purpose to offer correct and actionable solutions to strengthen medical decision-making for people and their households. Invitae’s genetics consultants apply a rigorous strategy to information and analysis, serving as the inspiration of their mission to carry complete genetic info into mainstream drugs to enhance healthcare for billions of individuals.
To study extra, go to invitae.com and comply with for updates on Twitter, Instagram, Facebook and LinkedIn @Invitae.
Protected Harbor Assertion
This press launch accommodates forward-looking statements throughout the that means of the Personal Securities Litigation Reform Act of 1995, together with statements referring to Ms. Wen’s future help and repair with the Firm; Ms. Gorjanc’s future help and repair as interim CFO; and the Firm’s efforts to rent a everlasting CFO. Ahead-looking statements are topic to dangers and uncertainties that might trigger precise outcomes to vary materially, and reported outcomes shouldn’t be thought-about as a sign of future efficiency. These dangers and uncertainties embrace, however are usually not restricted to: the corporate’s means to develop its enterprise in a cost-efficient method; the corporate’s historical past of losses; the corporate’s means to keep up vital buyer relationships; the corporate’s means to compete; the corporate’s failure to handle progress successfully; the corporate’s must scale its infrastructure prematurely of demand for its exams and to extend demand for its exams; dangers related to litigation; the corporate’s means to make use of quickly altering genetic information to interpret take a look at outcomes precisely and constantly; safety breaches, lack of information and different disruptions; legal guidelines and rules relevant to the corporate’s enterprise; and the opposite dangers set forth within the firm’s filings with the Securities and Trade Fee, together with the dangers set forth within the firm’s Quarterly Report on Type 10-Q for the quarter ended March 31, 2023. These forward-looking statements converse solely as of the date hereof, and Invitae Company disclaims any obligation to replace these forward-looking statements.
SOURCE Invitae Company